M/S. MYLAN PHARMACEUTICALS INC, — Sodium Importer Profile
Pharmaceutical Importer · #18 buyer for Sodium · $1.7M import value · 37 shipments · UNITED STATES · DGFT Verified
M/S. MYLAN PHARMACEUTICALS INC, is the #18 importer of Sodium from India with $1.7M in import value and 37 verified shipments. M/S. MYLAN PHARMACEUTICALS INC, holds a 0.5% market share in Sodium imports based in UNITED STATES. The company sources from 1 verified supplier across 2 formulations shipped to 1 country. Overall, M/S. MYLAN PHARMACEUTICALS INC, imports 9 pharmaceutical products worth $8.0M across 7 therapeutic categories.
M/S. MYLAN PHARMACEUTICALS INC, — Sodium Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Sodium to M/S. MYLAN PHARMACEUTICALS INC,?
Verified from 37 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MYLAN LABORATORIES LIMITED | $1.7M | 37 | 100.0% |
M/S. MYLAN PHARMACEUTICALS INC, sources Sodium from 1 verified Indian supplier based on 37 customs records. The primary supplier is MYLAN LABORATORIES LIMITED accounting for 100.0% of imports.
How Does M/S. MYLAN PHARMACEUTICALS INC, Compare to Nearest Sodium Importers?
Buyers ranked immediately above and below #18 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | MYLAN PHARMACEUTICALS INC, | UNITED STATES | $2.5M | 50 | $50.0K |
| 14 | NATIONAL MEDICAL STORES | KENYA | $2.2M | 44 | $50.0K |
| 18 | M/S. MYLAN PHARMACEUTICALS INC, ★ | UNITED STATES | $1.9M | 37 | $50.0K |
| 4 | MINISTRY OF HEALTH | SEYCHELLES | $1.8M | 36 | $50.0K |
| 7 | RANBAXY FARMACEUTICA LTDA | BRAZIL | $1.6M | 33 | $50.0K |
M/S. MYLAN PHARMACEUTICALS INC, ranks #18 among 2,469 Sodium importers from India. Average shipment value of $50.0K compared to the market average of $24.1K. The closest competitors by value are MYLAN PHARMACEUTICALS INC, and NATIONAL MEDICAL STORES.
Where Does M/S. MYLAN PHARMACEUTICALS INC, Import Sodium To?
Destination countries from 37 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.7M | 37 | 100.0% |
M/S. MYLAN PHARMACEUTICALS INC, imports Sodium to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $1.7M.
What Sodium Formulations Does M/S. MYLAN PHARMACEUTICALS INC, Import?
| Formulation | Value | Shipments |
|---|---|---|
| PANTOPRAZOLE SODIUM DELAYED-RELEASE TABL | $1.2M | 26 |
| PANTOPRAZOLE SODIUM DELAYED RELEASE TABL | $518.2K | 11 |
M/S. MYLAN PHARMACEUTICALS INC, imports 2 distinct Sodium formulations from India. The top formulation is PANTOPRAZOLE SODIUM DELAYED-RELEASE TABL with 26 shipments worth $1.2M.
Regulatory Requirements: Importing Sodium into United States
What M/S. MYLAN PHARMACEUTICALS INC, and other importers must comply with to import Sodium from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Sodium
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Sodium from India and How Much Does M/S. MYLAN PHARMACEUTICALS INC, Import?
India exported $59.4M worth of Sodium through 15,000 shipments from 985 suppliers to 177 countries, serving 2,469 buyers globally. M/S. MYLAN PHARMACEUTICALS INC, imports $1.7M of this total, accounting for 0.5% of India's Sodium exports with 37 shipments from UNITED STATES. This is verified from 37 customs shipment records covering 2 distinct formulations.
What Is the Average Order Value for M/S. MYLAN PHARMACEUTICALS INC,'s Sodium Imports?
M/S. MYLAN PHARMACEUTICALS INC,'s average Sodium order value is $46.3K per consignment, based on 37 shipments totaling $1.7M. M/S. MYLAN PHARMACEUTICALS INC, is based in UNITED STATES and ranks #18 among all Sodium importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Sodium to M/S. MYLAN PHARMACEUTICALS INC,?
M/S. MYLAN PHARMACEUTICALS INC, sources Sodium from 1 verified Indian supplier: MYLAN LABORATORIES LIMITED ($1.7M, 100.0%). This is based on 37 customs records.
How Does M/S. MYLAN PHARMACEUTICALS INC, Compare to Other Sodium Importers?
M/S. MYLAN PHARMACEUTICALS INC, ranks #18 among 2,469 Sodium importers from India with a 0.5% market share. The top 3 importers are CIPLA USA INC UPS SUPPLY CHAIN SOLU ($10.7M), UNICHEM PHARMACEUTICALS (USA) INC. ($7.0M), PLANET PHARMA ($5.8M). M/S. MYLAN PHARMACEUTICALS INC, processed 37 shipments from UNITED STATES.
About M/S. MYLAN PHARMACEUTICALS INC,
M/S. MYLAN PHARMACEUTICALS INC, imports 9 products worth $8.0M. Beyond Sodium, top products include Pantoprazole, Valsartan, Hydrochlorothiazide, Acyclovir, Valacyclovir. View the complete M/S. MYLAN PHARMACEUTICALS INC, profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Sodium — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Sodium shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: M/S. MYLAN PHARMACEUTICALS INC, matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as M/S. MYLAN PHARMACEUTICALS INC,'s capped import value divided by total capped export value for Sodium across all Indian exporters.
- 5.Verified Records: This page is backed by 37 individual customs records matching M/S. MYLAN PHARMACEUTICALS INC, importing Sodium, covering 2 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 177+ countries, 2,469+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Sodium Import Data for M/S. MYLAN PHARMACEUTICALS INC,
Access order-level details, pricing data, supplier connections, and competitive analysis for M/S. MYLAN PHARMACEUTICALS INC,'s Sodium imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
M/S. MYLAN PHARMACEUTICALS INC,
Full Company Profile →
9 products · $8.0M total trade · 7 categories
M/S. MYLAN PHARMACEUTICALS INC, × Sodium
Verified from customs records
Company Overview
Top Products by M/S. MYLAN PHARMACEUTICALS INC,
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for M/S. MYLAN PHARMACEUTICALS INC,.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Sodium. For current order-level data, contact TransData Nexus.